Jump to content
RemedySpot.com

FDA panel rejects Merck drug for prostate cancer

Rate this topic


Guest guest

Recommended Posts

Allowing a drug to be used for A particular purpose and recommending it be used for that purpose are two very different things. Neither Finasteride or Adovart are being removed from the market. All that has happened is that the FDA, not being the ship of fools that they have been so often in the past, have decided not to stick their collective necks in the noose and actually recommend that these drugs be used by men who have neither Prostate cancer or BPH, yet. With the legacy of the female hormone replacement disaster fresh in their minds, it did not take much insight to know which way they would rule. Tens of thousands of women, maybe millions of women were directly harmed by an FDA approved hormone replacment protocol experiment that lasted quarter of a century. I seriously doubt that the FDA is looking

for a repeat of that colossal mistake. The litigation when untoward side effects begin to emerge with long term use would swamp the courts and I don't believe that the current crop of FDA employees fancy spending their retirement testifying at congressional hearings and perhaps being brought up on charges.

BOB

Subject: FDA panel rejects Merck drug for prostate cancerTo: "hrpca group" <hrpca >, "PCa Under Yahoo Group" <prostatecancerunder50 >, "PPML List" , "Yahoo PCaGroup" <ProstateCancerSupport >Date: Wednesday, December 1, 2010, 5:34 PM

This is for Proscar and it sounds like Avodart is next on the hit list.

http://www.wtop.com/?nid=111 & sid=2184761-- Emersonwww.flhw.orgEvery 2.25 minutes a man is diagnosed with prostate cancer.Every 16.5 minutes a man dies from the disease.

Link to comment
Share on other sites

Off-label use is not illegal, unethical or uncommon. In 20 years as a practicing

PA, I did it often, especially for AIDS patients, and had many a battle with

Medicaid pharmacists because of it. Some drugs we prescribed were chosen for

what were considered their side-effects, such as Megace and Marinol as appetite

stimulants.

Subject: FDA panel rejects Merck drug for prostate

cancer

To: " hrpca group " <hrpca >, " PCa Under Yahoo Group "

<prostatecancerunder50 >, " PPML List " , " Yahoo

PCaGroup " <ProstateCancerSupport >

Date: Wednesday, December 1, 2010, 5:34 PM

This is for Proscar and it sounds like Avodart is next on the hit list.

http://www.wtop.com/?nid=111 & sid=2184761

Emerson

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...